Li Tan, Ph.D
Affiliations: | 2000-2004 | Nanjing University, Nanjing Shi, Jiangsu Sheng, China | |
2004-2009 | SIOC,CAS | ||
2010-2016 | Harvard Medical School, Dana Farber Cancer Institute | ||
2016- | SIOC,CAS |
Google:
"Li Tan"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Tao Y, Xia W, Zhao Q, et al. (2023) Structural mechanism for specific binding of chemical compounds to amyloid fibrils. Nature Chemical Biology |
Chan S, Zhang Y, Wang J, et al. (2022) Discovery of 3-Aminopyrazole Derivatives as New Potent and Orally Bioavailable AXL Inhibitors. Journal of Medicinal Chemistry |
Tan L, Shan H, Han C, et al. (2022) Discovery of Potent OTUB1/USP8 Dual Inhibitors Targeting Proteostasis in Non-Small-Cell Lung Cancer. Journal of Medicinal Chemistry |
Donovan KA, Ferguson FM, Bushman JW, et al. (2020) Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development. Cell |
Schröder M, Tan L, Wang J, et al. (2020) Catalytic Domain Plasticity of MKK7 Reveals Structural Mechanisms of Allosteric Activation and Diverse Targeting Opportunities. Cell Chemical Biology |
Pinch BJ, Doctor ZM, Nabet B, et al. (2020) Identification of a potent and selective covalent Pin1 inhibitor. Nature Chemical Biology |
Zhang YH, Li YF, Wang Y, et al. (2020) Identification and characterization of N9-methyltransferase involved in converting caffeine into non-stimulatory theacrine in tea. Nature Communications. 11: 1473 |
Tan L, Zhang Z, Gao D, et al. (2019) Quinolone antibiotic derivatives as new selective Axl kinase inhibitors. European Journal of Medicinal Chemistry. 166: 318-327 |
Pinch B, Doctor Z, Browne CM, et al. (2019) Abstract 2757: Discovery and characterization of covalent Pin1 inhibitors targeted to an active site cysteine Cancer Research. 79: 2757-2757 |
Kozono S, Lin YM, Seo HS, et al. (2018) Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells. Nature Communications. 9: 3069 |